I maintain a clinical practice that includes both medical and surgical treatment of gynecologic cancers, and I have been widely recognized by my peers for excellence in both clinical practice and teaching. In addition, I have been consistently named to the Castle Connolly list of top doctors.

At Ohio State’s Comprehensive Cancer Center, I am a member of the Translational Therapeutics Program. My research focuses on identifying biomarkers for early detection and prevention of ovarian cancer, as well as on the genetics of endometrial (uterine) cancer. I have published nearly 300 manuscripts in scientific journals and several book chapters, and I hold two patents – one for early detection of ovarian cancer and the other for a novel vaccination strategy for treating this disease.

Nationally, I have served as co-chair of the National Cancer Institute NRG Oncology’s Cancer Care Delivery Committee, and as president of the Society of Gynecologic Oncology (SGO). In January 2022 I became editor-in-chief of the journal Gynecologic Oncology, an international journal devoted to the publication of clinical and investigative articles about tumors of the female reproductive tract. I had been a deputy editor for that journal – the official publication of the SGO – since 2011.